Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27811224 | 0.84 | — | — | |
| SCHEMBL44010 | 0.84 | — | — | |
| SCHEMBL27967282 | 0.84 | — | — | |
| SCHEMBL27602312 | 0.82 | — | — | |
| SCHEMBL5964870 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL11497228 | 0.82 | — | — | |
| Glycerin SCHEMBL569689 | 0.79 | LMNA (0.60) | TSHRLMNAALDH1A1CA1CA2 | |
| Propane SCHEMBL6689593 | 0.77 | USP2 (0.45) | TSHRLMNAALDH1A1USP2THRB | |
| Glycerin SCHEMBL27945356 | 0.76 | LMNA (0.56) | TSHRLMNAALDH1A1CA1CA2 | |
| Allyl Alcohol SCHEMBL27836124 | 0.76 | LMNA (0.41) | TSHRLMNAALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2510788-B1 | Glyceryl ether compounds and their use | SEGETIS INC (US) | 2015-03-18 | — | — | EP | disclosed |
| US-8575371-B2 | Glyceryl ether compounds and their use | SEGETIS, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-20130046102-A1 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | SEGETIS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| US-8318814-B2 | Glyceryl ether compounds and their use | SEGETIS, INC. (US) | 2012-11-27 | — | — | US | disclosed |
| EP-2510788-A2 | Glyceryl ether compounds and their use | Segetis, Inc. (US) | 2012-10-17 | — | — | EP | disclosed |
| US-20120101313-A1 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | SEGETIS, INC. (US) | 2012-04-26 | — | — | US | disclosed |
| US-8084635-B2 | Glyceryl ether compounds and their use | SEGETIS, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-8026378-B2 | Glyceryl ether compounds and their use | SEGETIS, INC. (US) | 2011-09-27 | — | — | US | disclosed |
| US-20110218350-A1 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | SEGETIS, INC. (US) | 2011-09-08 | — | — | US | disclosed |
| US-20100222603-A1 | Glyceryl Ether Compounds and their Use | GFBIOCHEMICALS LIMITED (MT) | 2010-09-02 | — | — | US | disclosed |
| EP-1954139-A2 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | Aromagen Corporation (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007062112-A2 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | AROMAGEN CORPORATION (US) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222603-A1 | Glyceryl Ether Compounds and their Use | DAGLA, DAGLB, MGLL | TSHR 3558/4885LMNA 2208/4885ALDH1A1 1777/4885 |
| US-20120101313-A1 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | DAGLA, DAGLB, MGLL | TSHR 3558/4885LMNA 2208/4885ALDH1A1 1777/4885 |
| US-20110218350-A1 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | DAGLA, DAGLB, MGLL | TSHR 3558/4885LMNA 2208/4885ALDH1A1 1777/4885 |
| US-20130046102-A1 | GLYCERYL ETHER COMPOUNDS AND THEIR USE | DAGLA, DAGLB, MGLL | TSHR 3558/4885LMNA 2208/4885ALDH1A1 1777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.